NASDAQ: AMGN
Amgen Inc Stock Ownership - Who owns Amgen?

Insider buying vs selling

Have Amgen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rachna KhoslaSVP Business Development2025-06-051,500$289.68
$434.52kSell
Robert A. BradwayChairman CEO and President2025-05-022,481$283.78
$704.06kSell
Robert A. BradwayChairman CEO and President2025-05-022,352$283.78
$667.45kSell
Murdo GordonEVP Global Commercial Ops2025-05-02740$283.78
$210.00kSell
Matthew C. BuschVP Finance CAO2025-05-0228$283.78
$7.95kSell
Matthew C. BuschVP Finance CAO2025-05-0237$283.78
$10.50kSell
Matthew C. BuschVP Finance CAO2025-05-021,000$279.69
$279.69kSell
Murdo GordonEVP Global Commercial Ops2025-05-02780$283.78
$221.35kSell
Jonathan P. GrahamEVP Gen. Counsel Secy.2025-05-02609$283.78
$172.82kSell
Jonathan P. GrahamEVP Gen. Counsel Secy.2025-05-02592$283.78
$168.00kSell

1 of 6

AMGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMGN insiders and whales buy or sell their stock.

AMGN Shareholders

What type of owners hold Amgen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.83%52,870,453$15.72BInstitution
Blackrock Inc8.45%45,439,431$13.51BInstitution
State Street Corp5.43%29,179,991$8.67BInstitution
Capital World Investors3.11%16,701,609$4.97BInstitution
Morgan Stanley3.02%16,234,121$4.83BInstitution
Capital International Investors2.81%15,134,865$4.50BInstitution
Geode Capital Management LLC2.37%12,727,346$3.78BInstitution
Primecap Management Co2.30%12,388,295$3.68BInstitution
Charles Schwab Investment Management Inc2.27%12,205,942$3.63BInstitution
Wells Fargo Company1.35%7,251,482$2.16BInstitution

1 of 3

AMGN vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMGN78.24%1.00%Net SellingNet Selling
PFE64.21%0.27%Net Buying
GILD83.47%1.11%Net SellingNet Selling
SNY20.68%0.00%
MRK76.86%0.22%Net BuyingNet Buying

Amgen Stock Ownership FAQ

Who owns Amgen?

Amgen (NASDAQ: AMGN) is owned by 78.24% institutional shareholders, 1.00% Amgen insiders, and 20.77% retail investors. Vanguard Group Inc is the largest individual Amgen shareholder, owning 52.87M shares representing 9.83% of the company. Vanguard Group Inc's Amgen shares are currently valued at $15.61B.

If you're new to stock investing, here's how to buy Amgen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.